A positive blood pad with no red cells on microscopy, or a weak protein pad with a turbid sulfosalicylic acid reaction, needs investigation before the urinalysis is reported. Urine reagent strips combine several chemical reactions on one plastic carrier. The pads provide qualitative or semiquantitative results, depending on the analyte and strip system. Each has its own reading time, sensitivity, and interferences. Reliable interpretation requires correct technique and correlation with related pad results, specimen concentration, and microscopy. When a strip result conflicts with the rest of the urinalysis, check specimen quality and method limitations, and choose follow-up testing for the suspected problem.1
For the anatomic basis of these findings, see Nephron Structure and Urine Formation.
Strip workflow and quality control
The product instructions specify how to dip the strip, remove excess urine, time each reaction, store the strips, and perform quality control. Procedures differ among strip brands and automated readers. A routine manual workflow includes the following steps:
- Test a fresh, well-mixed specimen in a clean, dry container. Allow refrigerated urine to reach room temperature before mixing and testing.
- Check the strip container, lot, expiration date, reagent-pad appearance, and acceptable control results.
- Immerse every reagent pad and remove the strip immediately. For visual reading, start timing as the strip leaves the urine, then remove excess urine by the method specified in the product instructions. Fluid carried between pads can contaminate adjacent reactions.
- Compare each pad with the color chart at its stated time under adequate light, or place the strip in the validated automated reader according to its instructions.
- Record the result in the units and categories assigned to that strip system. Do not interpret color changes after the reading window.
For the visually read Siemens Multistix 10 SG example, the bottle label assigns 30 seconds to glucose and bilirubin, 40 seconds to ketones, 45 seconds to specific gravity, 60 seconds to blood, pH, protein, urobilinogen, and nitrite, and 120 seconds to leukocyte esterase. Other products follow their own label.2
Store reagent strips in their original, tightly closed container and protect them from moisture, heat, and light. Follow the manufacturer's instructions for storage temperature and stability after opening, and follow the laboratory's quality-control plan for control frequency. Negative and positive controls specified by the manufacturer or validated by the laboratory assess the entire testing process. For the Siemens method cited here, water is an unacceptable negative-control substitute because it lacks the ionic and chemical matrix of urine.2
When a result is unexpected, check specimen age, temperature, mixing, strip storage, expiration, timing, and control performance. Repeating the same strip method may reproduce the same interference. Select a follow-up test that uses an independent reaction or a more specific specimen.
Acid-base and concentration findings
pH
The pH pad contains acid-base indicators, commonly methyl red and bromthymol blue, that cover a broad range of approximately pH 5 to 9. Results are reported in discrete color steps. Diet, medications, systemic acid-base status, renal tubular function, and bacterial growth can all affect urine pH. Urease-producing organisms and prolonged storage may make a specimen more alkaline.
Urine pH supports the interpretation of crystals and stones and the assessment of renal acidification. Urine pH cannot establish renal tubular acidosis without serum chemistry and clinical findings. A pH meter provides a more precise measurement when the exact pH affects a procedure or clinical decision.1
A pH meter uses potentiometry, the measurement of electrical potential between an indicator electrode and a reference electrode. The glass indicator electrode responds to hydrogen ion activity. The reference electrode supplies a stable comparison potential. Calibration converts the measured voltage difference into pH units. This electrical measurement differs from matching the strip's indicator color. Mayo's UPH24 method describes a glass electrode, a calomel reference electrode, and a voltmeter. Other meters may use a different reference system.3
Specific gravity
The specific-gravity pad uses a polyelectrolyte and pH indicator to estimate ionic strength. As ionic concentration rises, hydrogen ions released from the polyelectrolyte change the indicator color. Results are usually reported in increments of 0.005.
Because the strip responds chiefly to ions, its result may disagree with methods that also detect nonionic solutes. Protein and alkaline pH can also affect some products. Refractometry responds to solute number and molecular mass. Osmolality counts dissolved particles. The Specific Gravity and Osmolality lesson compares these measurements and their interferences.
Protein and albumin findings
Routine protein pad
The conventional protein pad uses the protein error of indicators. At a constant acidic pH, protein accepts hydrogen ions from an indicator and changes its color. Albumin produces the strongest response. Globulins, immunoglobulin light chains, and other low-molecular-weight proteins can be present despite a weak or negative routine pad.
Highly alkaline or heavily buffered urine, prolonged contact between the strip and specimen, quaternary ammonium compounds, chlorhexidine, visible blood, and intense pigment can cause falsely increased reactions in susceptible products. A very dilute specimen may contain clinically important albumin at a concentration below the pad's detection limit. Interpret a trace or 1+ reaction alongside the specific gravity and quantitative albumin or protein results. 1,2
Proteinuria patterns reflect the source and mechanism of protein entry into urine:
Scroll sideways to see all columns
| Pattern | Mechanism and examples |
|---|---|
| Prerenal overflow | The filtered load exceeds tubular reabsorptive capacity, as with hemoglobin, myoglobin, or monoclonal immunoglobulin light chains. |
| Glomerular | Increased glomerular permeability allows albumin and, with greater injury, larger proteins to enter the filtrate. Exercise, fever, hypertension, preeclampsia, and glomerular disease can produce this pattern. |
| Tubular | Proximal tubular injury reduces reabsorption of normally filtered low-molecular-weight proteins. |
| Postrenal | Inflammation, infection, bleeding, or genital-tract contamination adds protein after glomerular filtration. |
Orthostatic proteinuria is increased after an upright period but is normal in a first-morning specimen collected after recumbency. Its significance depends on persistence, the amount and type of protein, urine sediment findings, kidney function, and the clinical setting.
Albumin-to-creatinine ratio
The urine albumin-to-creatinine ratio (UACR) partly corrects for differences in urine concentration. Kidney Disease: Improving Global Outcomes (KDIGO) classifies albuminuria as A1 below 30 mg/g, A2 from 30 to 300 mg/g, and A3 above 300 mg/g. The older term microalbuminuria names the A2 concentration range, a smaller amount of the same albumin molecule. Chronic kidney disease assessment combines UACR with estimated glomerular filtration rate and evidence that an abnormality persists for at least 3 months. When feasible, confirm a random UACR of 30 mg/g or greater with a subsequent first-morning specimen. Exercise, fever, infection, menstruation, and marked hyperglycemia can cause transient increases.4
Albumin-sensitive strips can screen for moderately increased albuminuria, but their categories and detection limits are product-specific. Confirm a positive screen with quantitative UACR.
Nonalbumin protein
Sulfosalicylic acid (SSA) precipitates a wider range of proteins than the conventional indicator pad, including globulins and immunoglobulin light chains. Follow the laboratory's validated procedure for specimen preparation, reagent concentration, volumes, timing, and turbidity grades. Radiographic contrast material and some medications can also produce turbidity. Use quantitative protein measurement and electrophoretic methods to investigate a clinically important discrepancy.
Bence Jones proteins are monoclonal free immunoglobulin light chains. They may produce a strong SSA reaction with a weak routine protein pad. The historical heat-precipitation test has inadequate sensitivity and specificity for current confirmation. Investigation may include serum protein electrophoresis, serum immunofixation, serum free-light-chain measurement, and urine electrophoresis with immunofixation as clinically indicated.5
Glucose and ketone findings
Glucose
The glucose pad couples two enzyme reactions. Glucose oxidase forms gluconic acid and hydrogen peroxide. Peroxidase then uses the peroxide to oxidize a chromogen. This reaction is specific for glucose. Oxidizing cleaning agents can produce false-positive color. Ascorbic acid, high specific gravity, cold urine, high ketone concentrations, and delayed testing with cellular or bacterial glucose consumption can decrease the reaction in susceptible products.1,2
The renal threshold for glucose varies among individuals and is commonly approximated as a plasma glucose concentration of 160 to 180 mg/dL. Glycosuria can accompany hyperglycemia, pregnancy, proximal tubular dysfunction, renal glucosuria, and sodium-glucose cotransporter 2 inhibitor therapy. Blood glucose and glycated hemoglobin guide diagnosis and routine diabetes monitoring. Urine glucose reflects only the tested specimen.6
In a heated alkaline reaction, copper-reduction tablets detect reducing substances by converting cupric ions to cuprous oxide. Glucose, galactose, fructose, lactose, pentoses, and some drug metabolites can react. Sucrose is nonreducing. A very high reducing-substance concentration can produce a pass-through color sequence. Observe the reaction continuously and read it according to the product instructions. Copper reduction cannot identify which reducing substance is present or confirm an enzymatic glucose result. Specific blood or chromatographic methods have replaced this broad screen in many clinical applications.
Ketones
Urine ketone pads use sodium nitroprusside to detect acetoacetate. Formulations that include glycine also increase acetone reactivity. The pad does not detect beta-hydroxybutyrate, often the predominant ketone body in diabetic ketoacidosis. Early ketoacidosis may therefore produce a urine result that understates the ketone burden. During treatment, beta-hydroxybutyrate is converted to acetoacetate, so urine ketone color may increase as the patient's metabolic condition improves. Direct blood beta-hydroxybutyrate is preferred for diagnosis and serial assessment of diabetic ketoacidosis when available.6,7
Starvation, prolonged vomiting, low-carbohydrate intake, malabsorption, and strenuous exercise can also increase ketone production. Acetoacetate degrades and acetone volatilizes during storage. Free sulfhydryl compounds, some medications, and intense urine pigment can interfere with nitroprusside reactions.
Heme and bile-pigment findings
Blood
The blood pad detects the pseudoperoxidase activity of heme. Intact erythrocytes often create a speckled pattern as individual cells lyse on the pad. Free hemoglobin and myoglobin tend to produce a more uniform color. The pattern suggests the source and does not identify the pigment.
A positive pad with erythrocytes on microscopy supports hematuria. When microscopy shows few or no erythrocytes, a positive pad suggests hemoglobinuria, myoglobinuria, lysed cells, or chemical interference. Menstrual contamination, oxidizing agents, microbial or plant peroxidases, ascorbic acid, high nitrite, high specific gravity, and an unmixed specimen can alter susceptible methods. A positive blood pad calls for microscopic examination to confirm microhematuria and count erythrocytes. 1,8
Clinical findings and additional tests distinguish the heme source. Creatine kinase and evidence of muscle injury support myoglobinuria. Plasma hemolysis markers and plasma color support hemoglobinuria. The historical ammonium sulfate precipitation test is method-dependent and has limited current use.
Bilirubin and urobilinogen
Conjugated bilirubin is water soluble and can enter urine. Albumin-bound unconjugated bilirubin is not filtered in an appreciable amount. A urine bilirubin pad uses a diazo reaction to form a colored azo compound. Light exposure, delayed testing, ascorbic acid, and high nitrite can lower bilirubin recovery. Phenazopyridine, indican, and other pigments can complicate color interpretation. A validated bilirubin tablet test can help investigate a questionable strip result. It uses a different test format but also relies on diazo chemistry. Review its own sensitivity and interference limits.10
Intestinal bacteria convert conjugated bilirubin to urobilinogen compounds. Some urobilinogen is reabsorbed, and a small portion appears in urine. Multistix uses Ehrlich chemistry based on p-diethylaminobenzaldehyde. Other products use a diazonium reaction. Formalin, light, delayed testing, high nitrite, porphobilinogen, medications, and pigment can interfere with specific systems. Strip performance near the low end cannot reliably establish a complete absence of urobilinogen.1,2
Correlating urine bilirubin with urobilinogen produces three classic patterns:
Scroll sideways to see all columns
| Pattern | Laboratory interpretation |
|---|---|
| Bilirubin positive with low urobilinogen | Reduced delivery of conjugated bilirubin to the intestine, as in biliary obstruction, is possible. |
| Bilirubin positive with increased urobilinogen | Hepatocellular dysfunction can impair hepatic reuptake, and conjugated bilirubin reaches urine. |
| Bilirubin negative with increased urobilinogen | Increased bilirubin production, including hemolysis, can increase intestinal urobilinogen formation. |
Interpret these urine patterns with serum bilirubin fractions, liver enzymes, hemolysis studies, and clinical findings.
Nitrite and leukocyte esterase findings
The nitrite pad uses the Griess reaction. Many urinary gram-negative organisms reduce dietary nitrate to nitrite, which forms a pink azo dye on the pad. A positive result is relatively specific for bacteriuria in an appropriately collected specimen. Sensitivity varies with organism, dietary nitrate, bladder incubation time, bacterial concentration, antibiotic exposure, urine concentration, and ascorbic acid. Gram-positive organisms, yeasts, and organisms with limited nitrate-reducing activity may produce a negative result. A negative nitrite result cannot exclude a urinary tract infection.1
The leukocyte esterase pad detects esterase activity from granulocytes and some monocytes. An esterase hydrolyzes a substrate, and the product couples with a diazonium salt and forms a purple color. Lysed leukocytes can produce a positive reaction even when fewer intact cells remain for microscopy. Lymphocytes contribute little to the conventional reaction. High protein, glucose, specific gravity, oxalate, ascorbic acid, some medications, and early reading can reduce results in susceptible systems. Oxidants, formalin, pigment, and selected drugs can increase or obscure color. Leukocyte esterase color often develops later than other pad reactions, so read the pad at the product's stated time.
Scroll sideways to see all columns
| Nitrite | Leukocyte esterase | Interpretation and follow-up |
|---|---|---|
| Positive | Positive | The combination supports bacteriuria with pyuria. Symptoms, microscopy, and culture determine significance. |
| Positive | Negative | Bacteriuria remains possible. Early reading, leukocyte suppression, or chemical interference may account for the negative esterase reaction. |
| Negative | Positive | Pyuria remains possible with short bladder incubation, a nitrite-negative organism, antibiotics, contamination, stones, or nonbacterial inflammation. |
| Negative | Negative | Neither screen supports bacteriuria or pyuria. Specimen or clinical limitations may still warrant microscopy or culture. |
Interference flags and follow-up testing
Some strip systems include an ascorbic acid pad. A positive result indicates that vitamin C may suppress susceptible blood, glucose, bilirubin, nitrite, or leukocyte esterase reactions. Other products use chemical layers or reagents intended to reduce particular ascorbate effects. The product insert specifies which reactions need caution after a positive flag, because vitamin C does not invalidate every pad. The Multistix insert reports no interference from ascorbic acid at concentrations normally found in urine. That product claim does not establish resistance at every concentration or for other strip systems.2
Pigment, turbidity, medications, preservatives, cleaners, specimen age, and extreme concentration can also produce discordant results. Visual interpretation is especially uncertain when the specimen color resembles an endpoint color. Automated readers standardize illumination and timing and do not remove chemical interference.
Choose follow-up testing for the suspected interference. A different test format may share reaction chemistry, so check whether it supplies an independent measurement:
Scroll sideways to see all columns
| Strip concern | Useful follow-up |
|---|---|
| pH result requires precision | Calibrated pH meter |
| Protein result is persistent, unexpectedly weak, or discordant | Quantitative UACR or protein-to-creatinine ratio; protein electrophoresis and immunofixation when a monoclonal protein is suspected |
| Glucose result does not fit the clinical picture | Blood glucose or a validated quantitative glucose method |
| Diabetic ketoacidosis is suspected | Direct blood beta-hydroxybutyrate and blood acid-base assessment |
| Blood pad and microscopy disagree | Repeat microscopy on a fresh specimen, then muscle-injury or hemolysis studies as indicated |
| Bilirubin result is questionable | Validated bilirubin tablet test with its own interference review; serum fractionated bilirubin and liver tests provide additional context |
| Nitrite or leukocyte esterase conflicts with symptoms or microscopy | Urine microscopy and culture according to the clinical testing pathway |
| Specific gravity conflicts with specimen appearance or clinical expectation | Refractometry or osmolality, selected according to the measurement question |
ASCP BOC examination values
The American Society for Clinical Pathology (ASCP) Board of Certification (BOC) content guideline lists the following urine values for examination preparation. These examination values do not replace a laboratory's validated clinical reference intervals.9
Scroll sideways to see all columns
| Analyte | ASCP BOC examination value |
|---|---|
| Specific gravity | 1.003–1.035 |
| pH | 4.5–8.0 |
| Protein | Less than 10 mg/dL, trace, or negative |
| Bilirubin | Negative |
| Blood | Negative |
| Glucose | 15 mg/dL or less, or negative |
| Nitrite | Negative |
| Leukocyte esterase | Negative |
| Urobilinogen | Less than 1.0 Ehrlich unit; less than 17 µmol/L |
| Ketones | Less than 5 mg/dL or negative |
Practice
References
- Kouri TT, Hofmann W, Falbo R, et al. The EFLM European urinalysis guideline 2023. Clin Chem Lab Med. 2024;62(9):1653-1786. doi:10.1515/cclm-2024-0070 Back to text
- Siemens Healthineers. Multistix 10 SG Reagent Strips: Instructions for Use. 11306392 Rev A; 2017. Accessed August 28, 2026. https://doclib.siemens-healthineers.com/rest/v1/view?document-id=401929 Back to text
- Mayo Clinic Laboratories. pH, 24 Hour, Urine. Test ID UPH24. Method Description. Accessed September 7, 2026. Mayo test catalog. Back to text
- Kidney Disease: Improving Global Outcomes CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117-S314. doi:10.1016/j.kint.2023.10.018 Back to text
- Strasinger SK, Di Lorenzo MS. Urinalysis and Body Fluids. 7th ed. F.A. Davis; 2021. ISBN 978-0-8036-7582-7. F.A. Davis catalog record. Back to text
- Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2023;46(10):e151-e199. doi:10.2337/dci23-0036 Back to text
- Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care. 2024;47(8):1257-1275. doi:10.2337/dci24-0032 Back to text
- Barocas DA, Lotan Y, Matulewicz RS, et al. Updates to microhematuria: AUA/SUFU guideline (2025). J Urol. 2025;213(5):547-557. doi:10.1097/JU.0000000000004490 Back to text
- American Society for Clinical Pathology Board of Certification. MLS(ASCP) and MLS(ASCPi) Examination Content Guideline. Revised June 9, 2026. Accessed August 29, 2026. ASCP examination content guideline Back to text
- Siemens Healthineers. Ictotest Reagent Tablets. Chemical principles and limitations: diazonium coupling in a tablet format. Accessed September 13, 2026. This mechanism check does not establish regional IFU applicability or a universal interference limit. Back to text